| Skin Diseases and Diabetes | Lifetime | 20 | IT 2 | 98.91 |
| Genetic and rare skin diseases. | Lifetime | 27 | IT 3 | 98.93 |
| Cancer and Skin Lesions | Lifetime | 110 | IT 6 | 98.73 |
| Dermatological and Skeletal Disorders | Lifetime | 59 | IT 5 | 98.39 |
| Autoimmune Bullous Skin Diseases | Lifetime | 204 | IT 15 | 98.35 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 115 | IT 7 | 98.23 |
| Dermatological and COVID-19 studies | Lifetime | 44 | IT 5 | 96.48 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 271 | IT 22 | 97.29 |
| Oral Health Pathology and Treatment | Lifetime | 299 | IT 12 | 97.35 |
| Skin and Cellular Biology Research | Lifetime | 267 | IT 8 | 96.56 |
| Cutaneous Melanoma Detection and Management | Lifetime | 489 | IT 39 | 96.71 |
| Autoimmune and Inflammatory Disorders | Lifetime | 268 | IT 19 | 96.18 |
| Nail Diseases and Treatments | Lifetime | 659 | IT 35 | 95.36 |
| Vascular Malformations and Hemangiomas | Lifetime | 407 | IT 12 | 93.99 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 770 | IT 83 | 94.64 |
| Vascular Tumors and Angiosarcomas | Lifetime | 597 | IT 47 | 93.37 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 606 | IT 50 | 93.42 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 925 | IT 68 | 92.73 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 378 | IT 39 | 90.64 |
| Chemotherapy-related skin toxicity | Lifetime | 488 | IT 28 | 87.29 |
| Dupuytren's Contracture and Treatments | Lifetime | 279 | IT 8 | 85.75 |
| Histiocytic Disorders and Treatments | Lifetime | 920 | IT 65 | 82.59 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 574 | IT 71 | 76.36 |
| Genetic and rare skin diseases. | 2021-2025 | 20 | IT 3 | 89.88 |
| Skin Diseases and Diabetes | 2021-2025 | 32 | IT 3 | 88.17 |
| Cancer and Skin Lesions | 2021-2025 | 153 | IT 23 | 87.68 |
| Dermatological and COVID-19 studies | 2021-2025 | 106 | IT 32 | 82.34 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 623 | IT 65 | 85.68 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 464 | IT 63 | 82.48 |
| Dermatologic Treatments and Research | 2021-2025 | 953 | IT 78 | 73.52 |
| Dermatological and Skeletal Disorders | 2021-2025 | 225 | IT 44 | 70.57 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 892 | IT 92 | 69.67 |
| Drug-Induced Adverse Reactions | 2021-2025 | 810 | IT 65 | 69.12 |
| Dermatological diseases and infestations | 2021-2025 | 812 | IT 41 | 40.57 |
| Histiocytic Disorders and Treatments | 2021-2025 | 833 | IT 49 | 30.68 |
